Literature DB >> 21042981

Alvetex®: polystyrene scaffold technology for routine three dimensional cell culture.

Eleanor Knight1, Bridgid Murray, Ross Carnachan, Stefan Przyborski.   

Abstract

A broad range of technologies have been developed to enable three dimensional (3D) cell culture. Few if any however are adaptable for routine everyday use in a straightforward and cost effective manner. Alvetex(®) is a rigid highly porous polystyrene scaffold designed specifically to enable routine 3D cell culture. The scaffold is engineered into thin membranes that fit into conventional cell culture plasticware. The material is inert and offers a polystyrene substrate familiar to cell biologists worldwide. The 3D geometry of the scaffold provides the environment in which cells grow, differentiate, and function to form close relationships with adjacent cells thus creating the equivalent of a thin tissue layer in vitro. This chapter introduces the features required by a technology that enables routine 3D cell culture. Using Alvetex(®) as a product that satisfies these requirements, its application is demonstrated for the growth of a recognised cell line. Procedures detailing the use of Alvetex(®) for 3D cell culture are provided. This is followed by a series of detailed methods describing ways to analyse such cultures including histological techniques, immunocytochemistry, and scanning electron microscopy. Examples of data generated from these methods are shown in the corresponding figures. Additional notes are also included where further information about certain procedures is required. The use of Alvetex(®) in combination with these methods will enable investigators to routinely produce complex 3D cultures to research the growth, differentiation, and function of cells in new ways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21042981     DOI: 10.1007/978-1-60761-984-0_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

1.  Effect of PEG surface conformation on anticancer activity and blood circulation of nanoemulsions loaded with tocotrienol-rich fraction of palm oil.

Authors:  Alaadin Alayoubi; Saeed Alqahtani; Amal Kaddoumi; Sami Nazzal
Journal:  AAPS J       Date:  2013-08-30       Impact factor: 4.009

2.  Novel three dimensional human endocervix cultures respond to 28-day hormone treatment.

Authors:  Sevim Yildiz Arslan; Yanni Yu; Joanne E Burdette; Mary Ellen Pavone; Thomas J Hope; Teresa K Woodruff; J Julie Kim
Journal:  Endocrinology       Date:  2015-01-30       Impact factor: 4.736

3.  Applications of novel bioreactor technology to enhance the viability and function of cultured cells and tissues.

Authors:  H W Hoyle; L A Smith; R J Williams; S A Przyborski
Journal:  Interface Focus       Date:  2020-02-14       Impact factor: 3.906

4.  Astrocytes Grown in Alvetex(®) Three Dimensional Scaffolds Retain a Non-reactive Phenotype.

Authors:  Christopher I Ugbode; Warren D Hirst; Marcus Rattray
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

Review 5.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

6.  Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes.

Authors:  Lara Stevanato; Caroline Hicks; John D Sinden
Journal:  J Vis Exp       Date:  2015-04-12       Impact factor: 1.355

7.  Topographical cues regulate the crosstalk between MSCs and macrophages.

Authors:  Gema Vallés; Fátima Bensiamar; Lara Crespo; Manuel Arruebo; Nuria Vilaboa; Laura Saldaña
Journal:  Biomaterials       Date:  2014-10-28       Impact factor: 12.479

8.  Preparation of Primary Rat Hepatocyte Spheroids Utilizing the Liquid-Overlay Technique.

Authors:  Jonathan A Kyffin; Christopher R Cox; Joseph Leedale; Helen E Colley; Craig Murdoch; Pratibha Mistry; Steven D Webb; Parveen Sharma
Journal:  Curr Protoc Toxicol       Date:  2019-09

9.  The effects of microRNAs on human neural stem cell differentiation in two- and three-dimensional cultures.

Authors:  Lara Stevanato; John D Sinden
Journal:  Stem Cell Res Ther       Date:  2014-04-11       Impact factor: 6.832

10.  A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion.

Authors:  David S Hill; Neil D P Robinson; Matthew P Caley; Mei Chen; Edel A O'Toole; Jane L Armstrong; Stefan Przyborski; Penny E Lovat
Journal:  Mol Cancer Ther       Date:  2015-09-01       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.